Rita de Giuli

1.3k total citations
16 papers, 1.1k citations indexed

About

Rita de Giuli is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Rita de Giuli has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Oncology. Recurrent topics in Rita de Giuli's work include Ubiquitin and proteasome pathways (7 papers), Immunotherapy and Immune Responses (4 papers) and Viral Infections and Immunology Research (3 papers). Rita de Giuli is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Immunotherapy and Immune Responses (4 papers) and Viral Infections and Immunology Research (3 papers). Rita de Giuli collaborates with scholars based in Switzerland, Germany and United States. Rita de Giuli's co-authors include Marcus Groettrup, Gunter Schmidtke, Maries van den Broek, Selina Khan, Katrin Schwarz, Shahri Raasi, Pierre‐André Diener, Vincenzo Cerundolo, Francine Jotereau and Vincent Lotteau and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Rita de Giuli

15 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rita de Giuli Switzerland 13 556 425 299 200 175 16 1.1k
Gianna Fiorucci Italy 22 590 1.1× 522 1.2× 256 0.9× 253 1.3× 189 1.1× 48 1.3k
Maria Cristina Gauzzi Italy 17 290 0.5× 658 1.5× 377 1.3× 152 0.8× 242 1.4× 32 1.2k
Kaimei Song United States 17 415 0.7× 890 2.1× 389 1.3× 197 1.0× 206 1.2× 25 1.4k
Sylvie Beaulieu Canada 9 373 0.7× 801 1.9× 223 0.7× 81 0.4× 122 0.7× 13 1.2k
Mohammed Asmal United States 19 578 1.0× 313 0.7× 141 0.5× 246 1.2× 138 0.8× 41 1.1k
Olivier Manches France 21 345 0.6× 1.2k 2.9× 420 1.4× 327 1.6× 192 1.1× 44 1.8k
Suzanne Skoda‐Smith United States 13 394 0.7× 579 1.4× 137 0.5× 68 0.3× 167 1.0× 26 1.0k
Magdalena Filipowicz Sinnreich Switzerland 13 419 0.8× 551 1.3× 174 0.6× 69 0.3× 723 4.1× 22 1.6k
Nadia Alatrakchi United States 18 99 0.2× 447 1.1× 181 0.6× 366 1.8× 345 2.0× 27 1.1k
Veronica Bordoni Italy 19 225 0.4× 369 0.9× 113 0.4× 118 0.6× 139 0.8× 56 884

Countries citing papers authored by Rita de Giuli

Since Specialization
Citations

This map shows the geographic impact of Rita de Giuli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita de Giuli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita de Giuli more than expected).

Fields of papers citing papers by Rita de Giuli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita de Giuli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita de Giuli. The network helps show where Rita de Giuli may publish in the future.

Co-authorship network of co-authors of Rita de Giuli

This figure shows the co-authorship network connecting the top 25 collaborators of Rita de Giuli. A scholar is included among the top collaborators of Rita de Giuli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita de Giuli. Rita de Giuli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Nindl, Veronika, Reinhard Maier, Rita de Giuli, et al.. (2012). Cooperation of T h1 and T h17 cells determines transition from autoimmune myocarditis to dilated cardiomyopathy. European Journal of Immunology. 42(9). 2311–2321. 90 indexed citations
2.
Giuli, Rita de. (2011). Le classificazioni della disabilitŕ: dall'Icidh all'Icf. MINORIGIUSTIZIA. 40–45.
3.
Krebs, Philippe, Michael Kurrer, Marcel Kremer, et al.. (2007). Molecular mapping of autoimmune B cell responses in experimental myocarditis. Journal of Autoimmunity. 28(4). 224–233. 20 indexed citations
4.
Maier, Reinhard, Simone Miller, Michael Kurrer, et al.. (2005). Quantification and characterization of myosin peptide-specific CD4+ T cells in autoimmune myocarditis. Journal of Immunological Methods. 304(1-2). 117–125. 9 indexed citations
5.
Khan, Selina, Rita de Giuli, Gunter Schmidtke, et al.. (2001). Cutting Edge: Neosynthesis Is Required for the Presentation of a T Cell Epitope from a Long-Lived Viral Protein. The Journal of Immunology. 167(9). 4801–4804. 85 indexed citations
6.
Khan, Selina, Maries van den Broek, Katrin Schwarz, et al.. (2001). Immunoproteasomes Largely Replace Constitutive Proteasomes During an Antiviral and Antibacterial Immune Response in the Liver. The Journal of Immunology. 167(12). 6859–6868. 143 indexed citations
7.
Macagno, Annalisa, Lothar Kuehn, Rita de Giuli, & Marcus Groettrup. (2001). Pronounced up-regulation of the PA28α/β proteasome regulator but little increase in the steady-state content of immunoproteasome during dendritic cell maturation. European Journal of Immunology. 31(11). 3271–3280. 56 indexed citations
8.
Groettrup, Marcus, Maries van den Broek, Katrin Schwarz, et al.. (2001). Structural Plasticity of the Proteasome and Its Function in Antigen Processing. Critical Reviews in Immunology. 21(4). 21–21. 42 indexed citations
9.
Schwarz, Katrin, Rita de Giuli, Gunter Schmidtke, et al.. (2000). The Selective Proteasome Inhibitors Lactacystin and Epoxomicin Can Be Used to Either Up- or Down-Regulate Antigen Presentation at Nontoxic Doses. The Journal of Immunology. 164(12). 6147–6157. 88 indexed citations
10.
Schmidtke, Gunter, Hermann−Georg Holzhütter, Matthew Bogyo, et al.. (1999). How an Inhibitor of the HIV-I Protease Modulates Proteasome Activity. Journal of Biological Chemistry. 274(50). 35734–35740. 128 indexed citations
11.
Raasi, Shahri, Gunter Schmidtke, Rita de Giuli, & Marcus Groettrup. (1999). A ubiquitin-like protein which is synergistically inducible by interferon-γ and tumor necrosis factor-α. European Journal of Immunology. 29(12). 4030–4036. 113 indexed citations
12.
André, Patrice, Marcus Groettrup, Paul Klenerman, et al.. (1998). An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proceedings of the National Academy of Sciences. 95(22). 13120–13124. 232 indexed citations
13.
Lehnert, M., Rita de Giuli, Kathleen Kunke, et al.. (1996). Serum can inhibit reversal of multidrug resistance by chemosensitisers. European Journal of Cancer. 32(5). 862–867. 23 indexed citations
14.
Lehnert, M., Rita de Giuli, & P R Twentyman. (1996). Sensitive and rapid bioassay for analysis of P-glycoprotein-inhibiting activity of chemosensitizers in patient serum.. PubMed. 2(2). 403–10. 16 indexed citations
15.
Lehnert, M., Scott S. Emerson, William S. Dalton, Rita de Giuli, & S. E. Salmon. (1993). In vitro evaluation of chemosensitizers for clinical reversal of P-glycoprotein-associated Taxol resistance.. PubMed. 63–7. 16 indexed citations
16.
Westerhausen, M., et al.. (1981). Immunological changes following posttraumatic splenectomy. Annals of Hematology. 43(6). 345–353. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026